Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal Disease.

Saved in:
Bibliographic Details
Title: Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal Disease.
Authors: Riano I; Division of Hematology and Medical Oncology, Dartmouth Cancer Center, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NH., Velez MA; Department of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, CA., Pomares-Millan H; Department of Epidemiology, Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH., Blaquier J; Service of Neuro-Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL., Peshin S; Department of Internal Medicine, Norton Community Hospital, Norton, VA., Feldman J; EGFR Resisters, Chicago, IL., Velazquez AI; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. Electronic address: ana.velazquezmanana@ucsf.edu.
Source: Clinical lung cancer [Clin Lung Cancer] 2026 Jan; Vol. 27 (1), pp. 92-98. Date of Electronic Publication: 2025 Nov 22.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41468748
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Riano+I%22">Riano I</searchLink>; Division of Hematology and Medical Oncology, Dartmouth Cancer Center, Dartmouth Health, Geisel School of Medicine at Dartmouth, Lebanon, NH.<br /><searchLink fieldCode="AU" term="%22Velez+MA%22">Velez MA</searchLink>; Department of Medicine, Division of Hematology/Oncology, University of California, Los Angeles, CA.<br /><searchLink fieldCode="AU" term="%22Pomares-Millan+H%22">Pomares-Millan H</searchLink>; Department of Epidemiology, Dartmouth Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH.<br /><searchLink fieldCode="AU" term="%22Blaquier+J%22">Blaquier J</searchLink>; Service of Neuro-Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Peshin+S%22">Peshin S</searchLink>; Department of Internal Medicine, Norton Community Hospital, Norton, VA.<br /><searchLink fieldCode="AU" term="%22Feldman+J%22">Feldman J</searchLink>; EGFR Resisters, Chicago, IL.<br /><searchLink fieldCode="AU" term="%22Velazquez+AI%22">Velazquez AI</searchLink>; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. Electronic address: ana.velazquezmanana@ucsf.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100893225%22">Clinical lung cancer</searchLink> [Clin Lung Cancer] 2026 Jan; Vol. 27 (1), pp. 92-98. <i>Date of Electronic Publication: </i>2025 Nov 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100893225 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1938-0690 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215257304%22">15257304 </searchLink><i>NLM ISO Abbreviation: </i>Clin Lung Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41468748
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.cllc.2025.11.016
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 92
    Titles:
      – TitleFull: Expanding Lung Cancer Clinical Trial Criteria: A Systematic Review on Inclusion of Patients with Brain Metastases and Leptomeningeal Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Riano I
      – PersonEntity:
          Name:
            NameFull: Velez MA
      – PersonEntity:
          Name:
            NameFull: Pomares-Millan H
      – PersonEntity:
          Name:
            NameFull: Blaquier J
      – PersonEntity:
          Name:
            NameFull: Peshin S
      – PersonEntity:
          Name:
            NameFull: Feldman J
      – PersonEntity:
          Name:
            NameFull: Velazquez AI
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2026 Jan
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1938-0690
          Numbering:
            – Type: volume
              Value: 27
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical lung cancer
              Type: main
ResultId 1